Abstract: Equine cyathostomin are pervasive gastrointestinal parasites with wide-spread resistance to the benzimidazole and tetrahydropyrimidine drug classes worldwide. Combination deworming has been proposed as a more sustainable parasite control strategy. Simulation studies have found combination deworming to be effective in controlling drug resistant ovine trichostrongylid parasites. One equine study demonstrated an additive effect of a combination of oxibendazole and pyrantel pamoate against cyathostomins. However, this is the only equine study evaluating combination therapy, and the effects of repeated combination treatments administered over time remain unknown. The purpose of this study was to observe the efficacy of repeated oxibendazole/pyrantel pamoate combination therapy administered over one year against a cyathostomin population with resistance to benzimidazole and pyrantel products. Fecal egg counts were determined for the entire herd (N = 21) at the day of anthelmintic treatment and at two-week intervals for eight weeks post treatment. Starting efficacies of oxibendazole (OBZ, 10 mg/kg) and pyrantel pamoate (PYR, 6.6 mg base/kg) were 66.7% and 63.3%, respectively. Hereafter, the herd was treated four times with an oxibendazole/pyrantel pamoate combination, eight weeks apart, followed by repeating the single active treatments before concluding the study. While the first combination treatment exhibited an additive effect of the two active ingredients, this efficacy was not sustained over the course of the study. Mean fecal egg count reduction (FECR) was significantly greater for the first combination treatment (76.6%) than the second (42.6%, p = 0.0454), third (41.6%, p = 0.0318), and fourth (40.7%, p = 0.0372) combination treatments. The final single active mean FECRs were 42.3% for oxibendazole, and 42.7% for pyrantel pamoate. These efficacies were not significantly different from the initial single active efficacies (OBZ, p = 0.4421; PYR, p = 0.8361). These results suggest that combination therapy against double resistant equine cyathostomin populations is not sustainable, when using actives with markedly decreased starting efficacies.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research article investigates the efficacy of combination deworming against equine cyathostomin parasites resistant to benzimidazole and pyrantel drugs. The results suggest that while the combination treatment shows initial effectiveness, this is not sustained in the long term.
Research Background and Purpose
Equine cyathostomin parasites are commonly found within the gastrointestinal system of horses and have developed resistances to common deworming medications globally.
Using a combination of two drugs, oxibendazole and pyrantel pamoate, has been proposed as a potential solution to managing this resistance. Though this approach was effective in one previous study, no research has evaluated the long term effects of this treatment regimen.
The goal of this research was to evaluate the effectiveness of this combination therapy over a one-year period in a horse population already resistant to these drugs.
Research Methodology
This study involved a herd of 21 horses, all of whom were tested for parasite egg counts in their fecal matter at start of the study, two weeks later and then every eight weeks throughout the treatments.
The initial efficacy rates for the individual drugs, oxibendazole and pyrantel pamoate, were 66.7% and 63.3% respectively. In a sequence of four treatments administered every eight weeks, the combined drug treatment was applied, after which the individual drug treatments were once again given.
Research Findings
Although initially, the combination therapy demonstrated an additive effect, the efficacy declined over time. The reduction in mean fecal egg count was significantly greater for the first combination treatment (76.6%) in comparison to the second (42.6%), third (41.6%), and fourth (40.7%) treatments.
In terms of individual drugs, the final single active mean fecal egg count reductions were 42.3% for oxibendazole and 42.7% for pyrantel pamoate, with no significant difference from their initial efficacies.
Conclusion
The study concludes that while combination deworming therapy might show initial success, it fails to sustain its effectiveness over a longer period.
The strategy of using combination of drugs with decreased starting efficiencies does not represent a sustainable solution for the control of double-resistant equine cyathostomin populations.
Cite This Article
APA
Scare JA, Lyons ET, Wielgus KM, Nielsen MK.
(2018).
Combination deworming for the control of double-resistant cyathostomin parasites – short and long term consequences.
Vet Parasitol, 251, 112-118.
https://doi.org/10.1016/j.vetpar.2018.01.010
M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY, USA. Electronic address: Jessica.scare@uky.edu.
Lyons, E T
M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY, USA.
Wielgus, K M
College of Veterinary Medicine, Lincoln Memorial University, Harrogate, TN, USA.
Nielsen, M K
M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY, USA.